Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study
Authors
Keywords
-
Journal
OBESITY SURGERY
Volume 33, Issue 4, Pages 1017-1025
Publisher
Springer Science and Business Media LLC
Online
2023-02-11
DOI
10.1007/s11695-023-06484-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes
- (2022) Domenica M. Rubino et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effectiveness and Safety of Liraglutide in Managing Inadequate Weight Loss and Weight Regain after Primary and Revisional Bariatric Surgery: Anthropometric and Cardiometabolic Outcomes
- (2022) Wahiba Elhag et al. OBESITY SURGERY
- The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery—a Retrospective Analysis
- (2022) Anne Lautenbach et al. OBESITY SURGERY
- Revisional Surgery or Pharmacotherapy for Insufficient Weight Loss and Weight Regain After Primary Bariatric Procedure: a Descriptive Study
- (2022) Vanessa Malishree Dharmaratnam et al. OBESITY SURGERY
- Multidisciplinary Approach for Weight Regain—how to Manage this Challenging Condition: an Expert Review
- (2021) Maria Paula Carlin Cambi et al. OBESITY SURGERY
- Use of Weight Loss Medications in Patients after Bariatric Surgery
- (2021) Ilana P. Redmond et al. Current Obesity Reports
- Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
- (2021) Melanie Davies et al. LANCET
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- Do Gut Hormones Contribute to Weight Loss and Glycaemic Outcomes after Bariatric Surgery?
- (2021) Dimitris Papamargaritis et al. Nutrients
- Association of metabolic–bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants
- (2021) Nicholas L Syn et al. LANCET
- Are the Changes in Gastrointestinal Hormone Secretion Necessary for the Success of Bariatric Surgery? A Critical Review of the Literature
- (2021) Charalampos Lampropoulos et al. OBESITY SURGERY
- Initial Experience with Alternate-Day Liraglutide for Weight Regain Following Bariatric Surgery
- (2021) Miguel A. Rubio et al. OBESITY SURGERY
- Reversal of Long-Term Weight Regain After Roux-en-Y Gastric Bypass Using Liraglutide or Surgical Revision. A Prospective Study
- (2020) Fritz F. Horber et al. OBESITY SURGERY
- Benefits and Risks of Bariatric Surgery in Adults
- (2020) David E. Arterburn et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Routine clinical use of liraglutide 3 mg for the treatment of obesity: Outcomes in non‐surgical and bariatric surgery patients
- (2019) Mohamed Suliman et al. DIABETES OBESITY & METABOLISM
- Liraglutide 3 mg as a weight-loss strategy after failed bariatric surgery in a patient with hypothalamic obesity following craniopharyngioma
- (2019) M. Bretault et al. DIABETES & METABOLISM
- Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial
- (2019) Richard Pratley et al. LANCET
- Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial
- (2019) Alexander Dimitri Miras et al. Lancet Diabetes & Endocrinology
- Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)
- (2019) M.S. Capehorn et al. DIABETES & METABOLISM
- Definitions of Long-Term Weight Regain and Their Associations with Clinical Outcomes
- (2019) Vera Voorwinde et al. OBESITY SURGERY
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2019) Søren L Kristensen et al. Lancet Diabetes & Endocrinology
- Efficacy of High-Dose Liraglutide as an Adjunct for Weight Loss in Patients with Prior Bariatric Surgery
- (2018) Peter Rye et al. OBESITY SURGERY
- Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
- (2018) Patrick M O'Neil et al. LANCET
- Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
- (2017) Christopher Sorli et al. Lancet Diabetes & Endocrinology
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Weight Loss with Liraglutide 3.0 mg Predicts 1-Year Weight Loss and is Associated with Improvements in Clinical Markers
- (2016) Ken Fujioka et al. Obesity
- Weight Regain Following Sleeve Gastrectomy—a Systematic Review
- (2016) Melanie Lauti et al. OBESITY SURGERY
- Weight regain after bariatric surgery—how should it be defined?
- (2016) Marius Nedelcu et al. Surgery for Obesity and Related Diseases
- Effectiveness and tolerability of liraglutide in patients with type 2 diabetes mellitus and obesity after bariatric surgery
- (2016) Juan J. Gorgojo-Martínez et al. Surgery for Obesity and Related Diseases
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
- (2015) Melanie J. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Weight Regain After Gastric Bypass: Influence of Gut Hormones
- (2015) Marco Aurelio Santo et al. OBESITY SURGERY
- Synergistic weight loss and diabetes resolution with exenatide administration after laparoscopic gastric banding
- (2008) Michael M. Rothkopf et al. Surgery for Obesity and Related Diseases
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search